Treatment of carpal tunnel syndrome with alpha-lipoic acid

European Review for Medical and Pharmacological Sciences

Volumn 13, Issue 2, 2009, Pages 133-139

  Di Geronimo, Gesualdo ^a   Caccese, A Fonzone ^a   Caruso, L ^a   Soldati, A ^a   Passaretti, U ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

lipoic acid; linolenic acid; Carpal tunnel syndrome; Electromyography

Indexed keywords

ALANERV; GAMMA LINOLENIC ACID; NEUROPROTECTIVE AGENT; THIOCTIC ACID; UNCLASSIFIED DRUG; VITAMIN B COMPLEX;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CARPAL TUNNEL SYNDROME; CONTROLLED STUDY; DRUG CAPSULE; DRUG EFFICACY; ELECTROMYOGRAM; FEMALE; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARPAL TUNNEL SYNDROME; DRUG COMBINATIONS; ELECTROMYOGRAPHY; FEMALE; GAMMA-LINOLENIC ACID; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; THIAMINE; THIOCTIC ACID; VITAMIN B 12; VITAMIN B 6; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 65649138806     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ATROSHI I, GUMMESSON C, JOHNSSON R, ORNSTEIN E, RANSTAM J, ROSÉN I. Prevalence of carpal tunnel syndrome in a general population. JAMA 1999; 282: 153-158.
2. STEVENS JC, SUN S, BEARD CM, O'FALLON WM, KURLAND L. Carpal tunnel syndrome in Rochester, Minnesota, 1961-1980. Neurology 1988; 38:134-138.
3. TANAKA S, WILD DK, SELIGMAN PJ, BEHRENS V, CAMERON L, PUTZ-ANDERSON V . The US prevalence of self-reported carpal tunnel syndrome: 1988 national health interview survey data. Am J Public Health 1994; 84:1846-1848.
4. FEUERSTEIN M, MILLER VL, BURRELL LM, BERGER R. Occupational upper extremity disorders in the federal workforce: Prevalence, health care expenditures, and patterns of work disability. J Occup Environ Med 1998; 40: 546-555.
5. VERDUGO RJ, SALINAS RS, CASTILLO J, CEA JG. Surgical versus non-surgical treatment for carpal tunnel syndrome [Review]. The Cochrane Library 2007, Issue 4: 1-12.
6. DE ANGELIS R, SALAFFI F, FILIPPUCCI E, GRASSI W. La terapia della sindrome del tunnel carpale. Reumatismo 2006; 58: 5-10.
7. O'CONNOR D, MARSHALL S, MASSY-WESTROPP N. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome (Review). The Cochrane Library 2007, Issue 4: 1-19.
8. PIAZZINI DB, APRILE I, FERRARA PE, BERTOUNI C, TONALI P, MAGGI L, RABINI A, PONTELLI S, PADUA L. A systematic review of conservative treatment of carpal tunnel syndrome. Clin Rehabil 2007; 21: 299-314.
9. GERRITSEN AAM, DE KROM MCTFM, STRUIJS MA, SCHOLTEN RJPM, DE VET HCW, BOUTER LM. Conservative treatment options for carpal tunnel syndrome: a systematic review of ran-domised controlled trials. J Neurol 2002; 249: 272-280.
10. AUFIERO E, STITIK TP, FOYE PM, CHEN B. Pyridoxine hydrochloride treatment of carpal tunnel syndrome: A review. Nutr Rev 2004; 62: 96-104.
11. PETERS TJ, KOTOWICZ J, NYKA W, KOZUBSKI W, KUZNETSOV V, VANDERBIST F, DE NIET S, MARCEREUIL D, COFFINER M. Treatment of alcoholic polyneuropathy with vitamin B complex: A randomised controlled trial. Alcohol Alcohol 2006; 41: 636-642.
12. SUN Y, LAI MS, LU CJ. Effectiveness of vitamin B12 on diabetic neuropathy: Systematic review of clinical controlled trials. Acta Neurol Taiwan 2005; 14: 48-54.
13. STEWART FOSTER T. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy. Diabetes Educ 2007; 33: 111-117.
14. ZIEGLER D. Treatment of diabetic neuropathy and neuropathic pain. Diabetes Care 2008; 31: S255-S261.
15. ZIEGLER D, HANEFELD M, RUHNAU KJ, HASCHE H, LOBISCH M, SCHUTTE K, KERUM G, MALESSA R. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III Study) ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999; 22: 1296-1301.
16. ZIEGLER D, AMETOV A, BARINOV A, DYCK PJ, GURIEVA I, LOW PA, MUNZEL U, YAKHNO N, RAZ I, NOVOSADOVA, M, MAUS J, SAMIGULLIN R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy. The SYDNEY II trial. Diabetes Care 2006; 29: 2365-2370.
17. ZIEGLER D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: A critical review. Treat Endocrinol 2004; 3: 173-189.
18. FAN YY, CHAPKIN RS. Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr 1998; 128: 1411-1414.
19. NO AUTHORS LISTED. Gamma-linolenic acid (GLA). Monograph. Altern Med Rev 2004; 9: 70-78.
20. JAMAL GA, CARMICHAEL H. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: A double-blind placebo-controlled trial. Diabet Med 1990; 7: 319-323.
21. VETRO A, MANTIA F, MANTIA R. Terapia dei conflitti disco-radicolari. Comparazione clinica tra ossigeno-ozono terapia paravertebrale e trattamento combinato ossigeno-ozono terapia e un prodotto a base di acido alfa-lipoico [ALAnerv]. Minerva Ortop Traumatol 2006; 57: 57-63.
22. PADUA R, PADUA L, ROMANINI E, ALILISA L. LUPPARELLI S, SANGUINETTI C . Versione Italiana del questionario Boston Carpal Tunnel. G It Ortoped Traumatol 1998; 24: 121-129.
23. GIANNINI F, CIONI R, MONDELLI M, PADUA R, GREGARI B, D'AMICO P, PADUA L. A new clini-cal scale of carpal tunnel syndrome: Validation of the measurement and clinical-neurophysiological assessment. Clin Neurophysiol 2002; 113: 71-77.
24. PADUA L. Carpal tunnel syndrome. Clin Neurophysiol 2006; 117: S37.
25. BELLOMO G, MIRABELLI F, SALIS A, VAIRETTI M, RICHELMI P, FINARDI G, THOR H, ORRENIUS R. Oxidative stress-induced plasma membrane blebbing and cytoskeletal alterations in normal and cancer cells. Ann NY Acad Sci 1988; 551: 128-130.
26. BELLOMO G, MIRABELLI F, RICHELMI P. Glutathione-mediated mechanism of defence against oxygen free radical-induced hepatotoxicity. Hum Toxicol 1989; 8: 152.
27. SMITH AR, SHENVI SV, WIDLANSKY M, SUH JH, HAGEN TM. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem 2004; 11: 1135-1146.
28. CAMERON NE, COTTER MA. Comparison of the effects of ascorbil gamma-linolenic acid and gamma-linolenic acid in the correction of neurovascular deficits in diabetic rats. Diabetologia 1996; 39: 1047-1054.
29. HOUNSON L, HORROBIN DF, TRITSCHLER H, CORDER R, TOMLISON DR. A lipoic acid gamma-linolenic acid conjugate is effective agaist multiple indices of experimental diabetic neuropathy. Diabetologia 1998; 41: 839-843.